Study of GSK1363089 in Metastatic Gastric Cancer

Clinical trial NCT00725712 · COMPLETED

Trial details

NCT number: NCT00725712
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Gastrointestinal Tract

Start date: 2007-03-31
Primary completion: 2009-11-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.